Current Oncology (Sep 2024)

Prevalence and Correlates of Depressive Symptoms among Patients with Cancer: A Cross-Sectional Study

  • Wei-Zhen Yu,
  • Hsin-Fang Wang,
  • Nurul Huda,
  • Yun Yen,
  • Yen-Lin Liu,
  • Chia-Sui Li,
  • Yen-Chung Ho,
  • Hsiu-Ju Chang

DOI
https://doi.org/10.3390/curroncol31100431
Journal volume & issue
Vol. 31, no. 10
pp. 5802 – 5820

Abstract

Read online

The purpose of this study was to identify the correlates of depressive symptoms and the prevalence of depression, distress, and demoralization among patients with cancer in Taiwan in relation to their sociodemographics. A cross-sectional study design with convenience sampling was used to recruit 191 consecutive patients with cancer from the Cancer Center of a teaching hospital in northern Taiwan. Multiple linear regression was applied to analyze the determinants of depressive symptoms. The prevalence rates of depression (including suspected cases), distress, and demoralization were 17.8%, 36.1%, and 32.5%, respectively. The regression model explained 42.2% of the total variance, with significant predictors including marital status, life dependence, comorbidity, demoralization, and distress. The results demonstrated that higher levels of distress and demoralization were associated with more depressive symptoms. Demoralization and distress played vital roles in moderating depressive symptoms among patients with cancer. Nursing interventions should integrate appropriate mental health services, such as alleviating distress and demoralization, to prevent the occurrence of depression in patients with cancer.

Keywords